- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
B Pharm arrested for manufacturing, distributing Alprazolam tablets, Triprolidine Hydrochloride and Codeine Phosphate syrup
The Delhi Police has arrested a B. Pharm and 2 others for manufacturing and distributing Alprazolam tablets and Triprolidine Hydrochloride and Codeine Phosphate syrup across the country.
The arrest followed the recovery of Tablets and syrup worth approximately Rs 1 crore. Machines used in the preparation of Triprolidine hydrochloride and Codeine Phosphate syrup including packaging materials were also seized from their possession.
According to PTI, police claimed to have busted a 'nationwide narco syndicate' involved in the manufacturing and distribution of banned narcotic drugs and psychotropic substances.
The accused were identified as Samaludden alias Sadik (28), a resident of Agra; Mohammad Gulzar (34), a resident of Narela; and Salman (28), a resident of Baghpat in Uttar Pradesh, the police said.
According to the police, the accused have connections with various distribution channels extending into Haryana, Delhi and Uttarakhand, indicating a complex inter-state operation.
"The entire syndicate was unearthed after a tip-off which was received on December 25," Special Commissioner of Police (Crime Branch) Devesh Chandra Srivastva said.
The officer further said the tip-off led to the arrest of the three accused who were in possession of 1.80 lakh tablets of Alprazolam tablets and 9,000 bottles of Triprolidine Hydrochloride and Codeine Phosphate Syrup.
He further said Samaludden, the kingpin of the syndicate, who also possess the degree of B.Pharma and Salman planned to set up a factory to manufacture the Codeine-based syrup and habit-forming drugs like Alphrazolam and Tramadol.
"Sadik has also a social media account in the name of Sandeep Saini. In that profile DP, he put the picture of medicine so that he can get customers through social media, without being identified. He had set up the factory in Bawana with the help of Salman and Gulzar," said the Special CP.
He further said Gulzar, a graphics designer, also registered a firm under the name Abheshifa pharmaceutical marketing company and he is the main associate of Salman and Sadik.
"He worked as the supervisor of illegal factory setup. He also designed the label of recovered medicines and also helped Sadik and Salman to get the labels printed illegally," he added.
The officer further said they were using forged manufacturing licence and batch numbers. Even the address and QR code mentioned on the recovered syrup were forged.
They also used a forged brand name. They were also planning to set up their own fake medicine manufacturing plant. For that purpose, they had already purchased the machine and printed packaging material in bulk.
"Further investigation is underway," said the Special CP.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751